MentionFox
Home › funding signals › Ventoux Biosciences, Inc
Form D · on the record

Ventoux Biosciences — $95K Form D filing, November 2026

Before you sell to, join or invest in Ventoux Biosciences, Inc

MentionFox check on Ventoux Biosciences, Inc: only 1 source on file so far (checked 13 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/ventoux-biosciences-inc-form-d-000004

Check Ventoux Biosciences, Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Ventoux Biosciences, Inc?

Ventoux Biosciences, Inc filed a Form D with the Securities and Exchange Commission on 2026-11-12.

Ventoux Biosciences, Inc filed a Form D notice of an exempt securities offering with the SEC on November 12, 2026. The filing reports $95K sold. Its industry group is Biotechnology. It names Kurt Harrington (Executive Officer, Director) (SEC Form D, November 12, 2026).

Sell to companies like Ventoux Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Ventoux Biosciences, Inc raised on Nov 12. 88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

Selling to Ventoux Biosciences, Inc? See who runs it and how to reach them, plus this week's 84 other newly funded companies.

Is this your company?

Key facts

Run the free check on Ventoux Biosciences, Inc →

Ventoux Biosciences, Inc

New Form D on file · 2026-11-12 · the record

$95K
raise on the record
D
filing
5
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-12
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2022
BasedENCINITAS, CALIFORNIA
CIK2002904
Accession0002002904-26-000004

Pitching, partnering or investing alongside them? See who really runs and owns Ventoux Biosciences, Inc.

Free to see. No signup.

What do you want to do with Ventoux Biosciences, Inc?

Get the full cited report on Ventoux Biosciences, Inc

What the filing shows about Ventoux Biosciences, Inc

  • 5 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Ventoux Biosciences, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Ventoux Biosciences, Inc up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Ventoux Biosciences, Inc's own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Ventoux Biosciences, Inc's address as 315 South Coast Highway 101, Suite U245, Encinitas, CA 92024.

What the filing says

  • Offered: $95,000. Sold: $95,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 5 had already invested. (filing)
  • Date of first sale: December 27, 2023. (filing)
  • Types of securities: Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Ventoux Biosciences, Inc See pricing

Is Ventoux Biosciences, Inc a real, registered company?

Ventoux Biosciences, Inc is a registered filer with the SEC (CIK 2002904) and has filed since 2026-11-12. 1 filing is on record, the latest on 2026-11-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Ventoux Biosciences, Inc?

Ventoux Biosciences, Inc's Form D of 2026-11-12 names Kurt Harrington as its officers, directors or promoters.

How much has Ventoux Biosciences, Inc raised?

Its new offerings report $95K sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $95K, filed week of Nov 9

Trailing twelve months. 757 filings in Biotechnology, totalled by week. The dot is this raise, $95K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Ventoux Biosciences, Inc?

What the filing shows about Ventoux Biosciences, Inc

  • 5 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Ventoux Biosciences, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Ventoux Biosciences, Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Ventoux Biosciences, Inc. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Ventoux Biosciences, Inc: Raised $95K, Form D filed 2026-11-12
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/ventoux-biosciences-inc-form-d-000004
Last updated 2026-11-13
Primary record: SEC filing 1 · SEC filing 2
Ventoux Biosciences raised $95K — SEC Form D filing, November 2026. MentionFox, 2026-11-13. https://mentionfox.com/funding/ventoux-biosciences-inc-form-d-000004